Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
104.8 USD | +1.81% | +0.22% | -4.77% |
12:02pm | Citigroup Adjusts Price Target on Abbott Laboratories to $119 From $128, Keeps Buy Rating | MT |
May. 15 | Abbott Laboratories Recalling HeartMate 3 Left Ventricular Assist System Implant Kit | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.77% | 179B | |
+4.10% | 113B | |
-3.85% | 67.88B | |
+5.19% | 52.03B | |
+5.54% | 43.3B | |
+4.03% | 41.79B | |
+23.81% | 32.49B | |
+14.00% | 25.65B | |
-5.06% | 24.55B | |
-1.95% | 24.48B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Transcript : Abbott Laboratories, Q4 2021 Earnings Call, Jan 26, 2022